Global Opioids Drug Market Growth 2021-2026

Global Opioids Drug Market Growth 2021-2026

Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Opioids Drug Consumption 2016-2026
2.1.2 Opioids Drug Consumption CAGR by Region
2.2 Opioids Drug Segment by Type
2.2.1 Oxycodone
2.2.2 Hydromorphone
2.2.3 Codeine
2.2.4 Fentanyl
2.3 Opioids Drug Sales by Type
2.3.1 Global Opioids Drug Sales Market Share by Type (2016-2021)
2.3.2 Global Opioids Drug Revenue and Market Share by Type (2016-2021)
2.3.3 Global Opioids Drug Sale Price by Type (2016-2021)
2.4 Opioids Drug Segment by Application
2.4.1 Pain Relief
2.4.2 Anesthesia
2.4.3 Others
2.5 Opioids Drug Sales by Application
2.5.1 Global Opioids Drug Sale Market Share by Application (2016-2021)
2.5.2 Global Opioids Drug Revenue and Market Share by Application (2016-2021)
2.5.3 Global Opioids Drug Sale Price by Application (2016-2021)

3 Global Opioids Drug by Company
3.1 Global Opioids Drug Sales Market Share by Company
3.1.1 Global Opioids Drug Sales by Company (2019-2021)
3.1.2 Global Opioids Drug Sales Market Share by Company (2019-2021)
3.2 Global Opioids Drug Revenue Market Share by Company
3.2.1 Global Opioids Drug Revenue by Company (2019-2021)
3.2.2 Global Opioids Drug Revenue Market Share by Company (2019-2021)
3.3 Global Opioids Drug Sale Price by Company
3.4 Global Manufacturers Opioids Drug Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Opioids Drug Product Location Distribution
3.4.2 Players Opioids Drug Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Opioids Drug by Region
4.1 Global Opioids Drug by Region
4.1.1 Global Opioids Drug Sales by Region
4.1.2 Global Opioids Drug Revenue by Region
4.2 Americas Opioids Drug Sales Growth
4.3 APAC Opioids Drug Sales Growth
4.4 Europe Opioids Drug Sales Growth
4.5 Middle East & Africa Opioids Drug Sales Growth

5 Americas
5.1 Americas Opioids Drug Sales by Country
5.1.1 Americas Opioids Drug Sales by Country (2016-2021)
5.1.2 Americas Opioids Drug Revenue by Country (2016-2021)
5.2 Americas Opioids Drug Sales by Type
5.3 Americas Opioids Drug Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC Opioids Drug Sales by Region
6.1.1 APAC Opioids Drug Sales by Region (2016-2021)
6.1.2 APAC Opioids Drug Revenue by Region (2016-2021)
6.2 APAC Opioids Drug Sales by Type
6.3 APAC Opioids Drug Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe Opioids Drug by Country
7.1.1 Europe Opioids Drug Sales by Country (2016-2021)
7.1.2 Europe Opioids Drug Revenue by Country (2016-2021)
7.2 Europe Opioids Drug Sales by Type
7.3 Europe Opioids Drug Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa Opioids Drug by Country
8.1.1 Middle East & Africa Opioids Drug Sales by Country (2016-2021)
8.1.2 Middle East & Africa Opioids Drug Revenue by Country (2016-2021)
8.2 Middle East & Africa Opioids Drug Sales by Type
8.3 Middle East & Africa Opioids Drug Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Opioids Drug Distributors
10.3 Opioids Drug Customer

11 Global Opioids Drug Market Forecast
11.1 Global Opioids Drug Forecast by Region
11.1.1 Global Opioids Drug Forecast by Regions (2021-2026)
11.2.2 Global Opioids Drug Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Country
11.3 APAC Forecast by Region
11.4 Europe Forecast by Country
11.5 Middle East & Africa Forecast by Country
11.6 Global Opioids Drug Forecast by Type
11.7 Global Opioids Drug Forecast by Application

12 Key Players Analysis
12.1 Teva
12.1.1 Teva Company Information
12.1.2 Teva Opioids Drug Product Offered
12.1.3 Teva Opioids Drug Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 Teva Main Business Overview
12.1.5 Teva Latest Developments
12.2 Purdue Pharma
12.2.1 Purdue Pharma Company Information
12.2.2 Purdue Pharma Opioids Drug Product Offered
12.2.3 Purdue Pharma Opioids Drug Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 Purdue Pharma Main Business Overview
12.2.5 Purdue Pharma Latest Developments
12.3 Mallinckrodt
12.3.1 Mallinckrodt Company Information
12.3.2 Mallinckrodt Opioids Drug Product Offered
12.3.3 Mallinckrodt Opioids Drug Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 Mallinckrodt Main Business Overview
12.3.5 Mallinckrodt Latest Developments
12.4 Amneal Pharma
12.4.1 Amneal Pharma Company Information
12.4.2 Amneal Pharma Opioids Drug Product Offered
12.4.3 Amneal Pharma Opioids Drug Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 Amneal Pharma Main Business Overview
12.4.5 Amneal Pharma Latest Developments
12.5 Collegium
12.5.1 Collegium Company Information
12.5.2 Collegium Opioids Drug Product Offered
12.5.3 Collegium Opioids Drug Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 Collegium Main Business Overview
12.5.5 Collegium Latest Developments
12.6 J&J
12.6.1 J&J Company Information
12.6.2 J&J Opioids Drug Product Offered
12.6.3 J&J Opioids Drug Sales, Revenue, Price and Gross Margin (2019-2021)
12.6.4 J&J Main Business Overview
12.6.5 J&J Latest Developments
12.7 Endo
12.7.1 Endo Company Information
12.7.2 Endo Opioids Drug Product Offered
12.7.3 Endo Opioids Drug Sales, Revenue, Price and Gross Margin (2019-2021)
12.7.4 Endo Main Business Overview
12.7.5 Endo Latest Developments
12.8 Pfizer
12.8.1 Pfizer Company Information
12.8.2 Pfizer Opioids Drug Product Offered
12.8.3 Pfizer Opioids Drug Sales, Revenue, Price and Gross Margin (2019-2021)
12.8.4 Pfizer Main Business Overview
12.8.5 Pfizer Latest Developments
12.9 INSYS
12.9.1 INSYS Company Information
12.9.2 INSYS Opioids Drug Product Offered
12.9.3 INSYS Opioids Drug Sales, Revenue, Price and Gross Margin (2019-2021)
12.9.4 INSYS Main Business Overview
12.9.5 INSYS Latest Developments
12.10 Mylan
12.10.1 Mylan Company Information
12.10.2 Mylan Opioids Drug Product Offered
12.10.3 Mylan Opioids Drug Sales, Revenue, Price and Gross Margin (2019-2021)
12.10.4 Mylan Main Business Overview
12.10.5 Mylan Latest Developments
12.11 Hikma
12.11.1 Hikma Company Information
12.11.2 Hikma Opioids Drug Product Offered
12.11.3 Hikma Opioids Drug Sales, Revenue, Price and Gross Margin (2019-2021)
12.11.4 Hikma Main Business Overview
12.11.5 Hikma Latest Developments
12.12 Egalet
12.12.1 Egalet Company Information
12.12.2 Egalet Opioids Drug Product Offered
12.12.3 Egalet Opioids Drug Sales, Revenue, Price and Gross Margin (2019-2021)
12.12.4 Egalet Main Business Overview
12.12.5 Egalet Latest Developments

13 Research Findings and Conclusion

List of Tables
Table 1. Opioids Drug Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Oxycodone
Table 3. Major Players of Hydromorphone
Table 4. Major Players of Codeine
Table 5. Major Players of Fentanyl
Table 6. Global Opioids Drug Sales by Type (2016-2021) & (M Units)
Table 7. Global Opioids Drug Sales Market Share by Type (2016-2021)
Table 8. Global Opioids Drug Revenue by Type (2016-2021) & ($ million)
Table 9. Global Opioids Drug Revenue Market Share by Type (2016-2021)
Table 10. Global Opioids Drug Sale Price by Type (2016-2021)
Table 11. Global Opioids Drug Sales by Application (2016-2021) & (M Units)
Table 12. Global Opioids Drug Sales Market Share by Application (2016-2021)
Table 13. Global Opioids Drug Value by Application (2016-2021)
Table 14. Global Opioids Drug Revenue Market Share by Application (2016-2021)
Table 15. Global Opioids Drug Sale Price by Application (2016-2021)
Table 16. Global Opioids Drug Sales by Company (2019-2021) & (M Units)
Table 17. Global Opioids Drug Sales Market Share by Company (2019-2021)
Table 18. Global Opioids Drug Revenue by Company (2019-2021) ($ Millions)
Table 19. Global Opioids Drug Revenue Market Share by Company (2019-2021)
Table 20. Global Opioids Drug Sale Price by Company (2019-2021)
Table 21. Key Manufacturers Opioids Drug Producing Area Distribution and Sales Area
Table 22. Players Opioids Drug Products Offered
Table 23. Opioids Drug Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Opioids Drug Sales by Region (2016-2021) (M Units)
Table 27. Global Opioids Drug Sales Market Share by Region (2016-2021)
Table 28. Global Opioids Drug Revenue by Region (2016-2021) & ($ Millions)
Table 29. Global Opioids Drug Revenue Market Share by Region (2016-2021)
Table 30. Americas Opioids Drug Sales by Country (2016-2021) & (M Units)
Table 31. Americas Opioids Drug Sales Market Share by Country (2016-2021)
Table 32. Americas Opioids Drug Revenue by Country (2016-2021) & ($ Millions)
Table 33. Americas Opioids Drug Revenue Market Share by Country (2016-2021)
Table 34. Americas Opioids Drug Sales by Type (2016-2021) & (M Units)
Table 35. Americas Opioids Drug Sales Market Share by Type (2016-2021)
Table 36. Americas Opioids Drug Sales by Application (2016-2021) & (M Units)
Table 37. Americas Opioids Drug Sales Market Share by Application (2016-2021)
Table 38. APAC Opioids Drug Sales by Region (2016-2021) & (M Units)
Table 39. APAC Opioids Drug Sales Market Share by Region (2016-2021)
Table 40. APAC Opioids Drug Revenue by Region (2016-2021) & ($ Millions)
Table 41. APAC Opioids Drug Revenue Market Share by Region (2016-2021)
Table 42. APAC Opioids Drug Sales by Type (2016-2021) & (M Units)
Table 43. APAC Opioids Drug Sales Market Share by Type (2016-2021)
Table 44. APAC Opioids Drug Sales by Application (2016-2021) & (M Units)
Table 45. APAC Opioids Drug Sales Market Share by Application (2016-2021)
Table 46. Europe Opioids Drug Sales by Country (2016-2021) & (M Units)
Table 47. Europe Opioids Drug Sales Market Share by Country (2016-2021)
Table 48. Europe Opioids Drug Revenue by Country (2016-2021) & ($ Millions)
Table 49. Europe Opioids Drug Revenue Market Share by Country (2016-2021)
Table 50. Europe Opioids Drug Sales by Type (2016-2021) & (M Units)
Table 51. Europe Opioids Drug Sales Market Share by Type (2016-2021)
Table 52. Europe Opioids Drug Sales by Application (2016-2021) & (M Units)
Table 53. Europe Opioids Drug Sales Market Share by Application (2016-2021)
Table 54. Middle East & Africa Opioids Drug Sales by Country (2016-2021) & (M Units)
Table 55. Middle East & Africa Opioids Drug Sales Market Share by Country (2016-2021)
Table 56. Middle East & Africa Opioids Drug Revenue by Country (2016-2021) & ($ Millions)
Table 57. Middle East & Africa Opioids Drug Revenue Market Share by Country (2016-2021)
Table 58. Middle East & Africa Opioids Drug Sales by Type (2016-2021) & (M Units)
Table 59. Middle East & Africa Opioids Drug Sales Market Share by Type (2016-2021)
Table 60. Middle East & Africa Opioids Drug Sales by Application (2016-2021) & (M Units)
Table 61. Middle East & Africa Opioids Drug Sales Market Share by Application (2016-2021)
Table 62. Key and Potential Regions of Opioids Drug
Table 63. Key Application and Potential Industries of Opioids Drug
Table 64. Key Challenges of Opioids Drug
Table 65. Key Trends of Opioids Drug
Table 66. Opioids Drug Distributors List
Table 67. Opioids Drug Customer List
Table 68. Global Opioids Drug Sales Forecast by Region (2021-2026) & (M Units)
Table 69. Global Opioids Drug Consumption Market Forecast by Region
Table 70. Global Opioids Drug Revenue Forecast by Region (2021-2026) & ($ millions)
Table 71. Global Opioids Drug Revenue Market Share Forecast by Region (2021-2026)
Table 72. Americas Opioids Drug Sales Forecast by Country (2021-2026) & (M Units)
Table 73. Americas Opioids Drug Revenue Forecast by Country (2021-2026) & ($ millions)
Table 74. APAC Opioids Drug Sales Forecast by Region (2021-2026) & (M Units)
Table 75. APAC Opioids Drug Revenue Forecast by Region (2021-2026) & ($ millions)
Table 76. Europe Opioids Drug Sales Forecast by Country (2021-2026) & (M Units)
Table 77. Europe Opioids Drug Revenue Forecast by Country (2021-2026) & ($ millions)
Table 78. Middle East & Africa Opioids Drug Sales Forecast by Country (2021-2026) & (M Units)
Table 79. Middle East & Africa Opioids Drug Revenue Forecast by Country (2021-2026) & ($ millions)
Table 80. Global Opioids Drug Sales Forecast by Type (2021-2026) & (M Units)
Table 81. Global Opioids Drug Sales Market Share Forecast by Type (2021-2026)
Table 82. Global Opioids Drug Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 83. Global Opioids Drug Revenue Market Share Forecast by Type (2021-2026)
Table 84. Global Opioids Drug Sales Forecast by Application (2021-2026) & (M Units)
Table 85. Global Opioids Drug Sales Market Share Forecast by Application (2021-2026)
Table 86. Global Opioids Drug Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 87. Global Opioids Drug Revenue Market Share Forecast by Application (2021-2026)
Table 88. Teva Basic Information, Opioids Drug Manufacturing Base, Sales Area and Its Competitors
Table 89. Teva Opioids Drug Product Offered
Table 90. Teva Opioids Drug Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 91. Teva Main Business
Table 92. Teva Latest Developments
Table 93. Purdue Pharma Basic Information, Opioids Drug Manufacturing Base, Sales Area and Its Competitors
Table 94. Purdue Pharma Opioids Drug Product Offered
Table 95. Purdue Pharma Opioids Drug Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 96. Purdue Pharma Main Business
Table 97. Purdue Pharma Latest Developments
Table 98. Mallinckrodt Basic Information, Opioids Drug Manufacturing Base, Sales Area and Its Competitors
Table 99. Mallinckrodt Opioids Drug Product Offered
Table 100. Mallinckrodt Opioids Drug Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 101. Mallinckrodt Main Business
Table 102. Mallinckrodt Latest Developments
Table 103. Amneal Pharma Basic Information, Opioids Drug Manufacturing Base, Sales Area and Its Competitors
Table 104. Amneal Pharma Opioids Drug Product Offered
Table 105. Amneal Pharma Opioids Drug Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 106. Amneal Pharma Main Business
Table 107. Amneal Pharma Latest Developments
Table 108. Collegium Basic Information, Opioids Drug Manufacturing Base, Sales Area and Its Competitors
Table 109. Collegium Opioids Drug Product Offered
Table 110. Collegium Opioids Drug Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 111. Collegium Main Business
Table 112. Collegium Latest Developments
Table 113. J&J Basic Information, Opioids Drug Manufacturing Base, Sales Area and Its Competitors
Table 114. J&J Opioids Drug Product Offered
Table 115. J&J Opioids Drug Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 116. J&J Main Business
Table 117. J&J Latest Developments
Table 118. Endo Basic Information, Opioids Drug Manufacturing Base, Sales Area and Its Competitors
Table 119. Endo Opioids Drug Product Offered
Table 120. Endo Opioids Drug Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 121. Endo Main Business
Table 122. Endo Latest Developments
Table 123. Pfizer Basic Information, Opioids Drug Manufacturing Base, Sales Area and Its Competitors
Table 124. Pfizer Opioids Drug Product Offered
Table 125. Pfizer Opioids Drug Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 126. Pfizer Main Business
Table 127. Pfizer Latest Developments
Table 128. INSYS Basic Information, Opioids Drug Manufacturing Base, Sales Area and Its Competitors
Table 129. INSYS Opioids Drug Product Offered
Table 130. INSYS Opioids Drug Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 131. INSYS Main Business
Table 132. INSYS Latest Developments
Table 133. Mylan Basic Information, Opioids Drug Manufacturing Base, Sales Area and Its Competitors
Table 134. Mylan Opioids Drug Product Offered
Table 135. Mylan Opioids Drug Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 136. Mylan Main Business
Table 137. Mylan Latest Developments
Table 138. Hikma Basic Information, Opioids Drug Manufacturing Base, Sales Area and Its Competitors
Table 139. Hikma Opioids Drug Product Offered
Table 140. Hikma Opioids Drug Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 141. Hikma Main Business
Table 142. Hikma Latest Developments
Table 143. Egalet Basic Information, Opioids Drug Manufacturing Base, Sales Area and Its Competitors
Table 144. Egalet Opioids Drug Product Offered
Table 145. Egalet Opioids Drug Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 146. Egalet Main Business
Table 147. Egalet Latest Developments
List of Figures
Figure 1. Picture of Opioids Drug
Figure 2. Opioids Drug Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Opioids Drug Sales Growth Rate 2016-2026 (M Units)
Figure 7. Global Opioids Drug Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. Opioids Drug Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of Oxycodone
Figure 10. Product Picture of Hydromorphone
Figure 11. Product Picture of Codeine
Figure 12. Product Picture of Fentanyl
Figure 13. Global Opioids Drug Sales Market Share by Type in 2020
Figure 14. Global Opioids Drug Revenue Market Share by Type (2016-2021)
Figure 15. Opioids Drug Consumed in Pain Relief
Figure 16. Global Opioids Drug Market: Pain Relief (2016-2021) & (M Units)
Figure 17. Opioids Drug Consumed in Anesthesia
Figure 18. Global Opioids Drug Market: Anesthesia (2016-2021) & (M Units)
Figure 19. Opioids Drug Consumed in Others
Figure 20. Global Opioids Drug Market: Others (2016-2021) & (M Units)
Figure 21. Global Opioids Drug Sales Market Share by Application (2016-2021)
Figure 22. Global Opioids Drug Revenue Market Share by Application in 2020
Figure 23. Opioids Drug Revenue Market by Company in 2020 ($ Million)
Figure 24. Global Opioids Drug Revenue Market Share by Company in 2020
Figure 25. Global Opioids Drug Sales Market Share by Regions (2016-2021)
Figure 26. Global Opioids Drug Revenue Market Share by Region in 2020
Figure 27. Americas Opioids Drug Sales 2016-2021 (M Units)
Figure 28. Americas Opioids Drug Revenue 2016-2021 ($ Millions)
Figure 29. APAC Opioids Drug Sales 2016-2021 (M Units)
Figure 30. APAC Opioids Drug Revenue 2016-2021 ($ Millions)
Figure 31. Europe Opioids Drug Sales 2016-2021 (M Units)
Figure 32. Europe Opioids Drug Revenue 2016-2021 ($ Millions)
Figure 33. Middle East & Africa Opioids Drug Sales 2016-2021 (M Units)
Figure 34. Middle East & Africa Opioids Drug Revenue 2016-2021 ($ Millions)
Figure 35. Americas Opioids Drug Sales Market Share by Country in 2020
Figure 36. Americas Opioids Drug Revenue Market Share by Country in 2020
Figure 37. Americas Opioids Drug Sales Market Share by Type in 2020
Figure 38. Americas Opioids Drug Sales Market Share by Application in 2020
Figure 39. United States Opioids Drug Revenue Growth 2016-2021 ($ Millions)
Figure 40. Canada Opioids Drug Revenue Growth 2016-2021 ($ Millions)
Figure 41. Mexico Opioids Drug Revenue Growth 2016-2021 ($ Millions)
Figure 42. Brazil Opioids Drug Revenue Growth 2016-2021 ($ Millions)
Figure 43. APAC Opioids Drug Sales Market Share by Region in 2020
Figure 44. APAC Opioids Drug Revenue Market Share by Regions in 2020
Figure 45. APAC Opioids Drug Sales Market Share by Type in 2020
Figure 46. APAC Opioids Drug Sales Market Share by Application in 2020
Figure 47. China Opioids Drug Revenue Growth 2016-2021 ($ Millions)
Figure 48. Japan Opioids Drug Revenue Growth 2016-2021 ($ Millions)
Figure 49. Korea Opioids Drug Revenue Growth 2016-2021 ($ Millions)
Figure 50. Southeast Asia Opioids Drug Revenue Growth 2016-2021 ($ Millions)
Figure 51. India Opioids Drug Revenue Growth 2016-2021 ($ Millions)
Figure 52. Australia Opioids Drug Revenue Growth 2016-2021 ($ Millions)
Figure 53. Europe Opioids Drug Sales Market Share by Country in 2020
Figure 54. Europe Opioids Drug Revenue Market Share by Country in 2020
Figure 55. Europe Opioids Drug Sales Market Share by Type in 2020
Figure 56. Europe Opioids Drug Sales Market Share by Application in 2020
Figure 57. Germany Opioids Drug Revenue Growth 2016-2021 ($ Millions)
Figure 58. France Opioids Drug Revenue Growth 2016-2021 ($ Millions)
Figure 59. UK Opioids Drug Revenue Growth 2016-2021 ($ Millions)
Figure 60. Italy Opioids Drug Revenue Growth 2016-2021 ($ Millions)
Figure 61. Russia Opioids Drug Revenue Growth 2016-2021 ($ Millions)
Figure 62. Middle East & Africa Opioids Drug Sales Market Share by Country in 2020
Figure 63. Middle East & Africa Opioids Drug Revenue Market Share by Country in 2020
Figure 64. Middle East & Africa Opioids Drug Sales Market Share by Type in 2020
Figure 65. Middle East & Africa Opioids Drug Sales Market Share by Application in 2020
Figure 66. Egypt Opioids Drug Revenue Growth 2016-2021 ($ Millions)
Figure 67. South Africa Opioids Drug Revenue Growth 2016-2021 ($ Millions)
Figure 68. Israel Opioids Drug Revenue Growth 2016-2021 ($ Millions)
Figure 69. Turkey Opioids Drug Revenue Growth 2016-2021 ($ Millions)
Figure 70. GCC Country Opioids Drug Revenue Growth 2016-2021 ($ Millions)
Figure 71. Channels of Distribution
Figure 72. Distributors Profiles

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Pain Management Drugs Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 93

Pain is complex, so there are many treatment options -- medications, therapies, and mind-body techniques. This report is mainly about The drugs for pain management. The global Pain Management Drugs market was valued at US$ 35360 million in 2023 and is anticipated to reach US$ 44550 million by 2030, witnessing a CAGR of 3.3% during The forecast period 2024-2030. The leading manufacturers in The industry are GSK, Pfizer and Grunenthal, which accounted for 14.42%, 13......

Global Pain Management Drugs Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 131

According to our LPI (LP Information) latest study, the global Pain Management Drugs market size was valued at US$ 34590 million in 2023. With growing demand in downstream market, the Pain Management Drugs is forecast to a readjusted size of US$ 43780 million by 2030 with a CAGR of 3.4% during review period. The research report highlights the growth potential of the global Pain Management Drugs market. Pain Management Drugs are expected to show stable growth in the future market. However......

Global Opioids Drug Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 115

According to our LPI (LP Information) latest study, the global Opioids Drug market size was valued at US$ 9831.4 million in 2023. With growing demand in downstream market, the Opioids Drug is forecast to a readjusted size of US$ 8616.1 million by 2030 with a CAGR of -1.9% during review period. The research report highlights the growth potential of the global Opioids Drug market. Opioids Drug are expected to show stable growth in the future market. However, product differentiation, reduci......

Global Methadone Hydrochloride Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 90

According to our LPI (LP Information) latest study, the global Methadone Hydrochloride market size was valued at US$ 63 million in 2023. With growing demand in downstream market, the Methadone Hydrochloride is forecast to a readjusted size of US$ 88 million by 2030 with a CAGR of 5.0% during review period. The research report highlights the growth potential of the global Methadone Hydrochloride market. Methadone Hydrochloride are expected to show stable growth in the future market. Howev......

Global Opioids Drugs Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 02-Jan-2024        Price: US 3380 Onwards        Pages: 112

Market Overview of Global Opioids Drugs market: According to our latest research, the global Opioids Drugs market looks promising in the next 5 years. As of 2022, the global Opioids Drugs market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Opioids are a class of drugs that include the illegal drug heroin, synthetic opioids such as fentanyl, and pain relievers available legally by prescript......

Global Opioids Drug Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 111

According to our (Global Info Research) latest study, the global Opioids Drug market size was valued at USD 10340 million in 2023 and is forecast to a readjusted size of USD 9156.6 million by 2030 with a CAGR of -1.7% during review period. Opioids are a class of drugs that include the illegal drug heroin, synthetic opioids such as fentanyl, and pain relievers available legally by prescription, such as oxycodone (OxyContin®), hydrocodone (Vicodin®), codeine, morphine, and many others. The......

Global Methadone Hydrochloride Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 87

According to our (Global Info Research) latest study, the global Methadone Hydrochloride market size was valued at USD 66 million in 2023 and is forecast to a readjusted size of USD 90 million by 2030 with a CAGR of 4.6% during review period. Methadone Hydrochloride is a white, crystalline material that is water-soluble. It is an opioid used to treat pain or as maintenance therapy to help with detoxification in people with opioid dependence. Market Competition is not intense, as t......

Global Pain Management Drugs Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 131

According to our (Global Info Research) latest study, the global Pain Management Drugs market size was valued at USD 36380 million in 2023 and is forecast to a readjusted size of USD 45230 million by 2030 with a CAGR of 3.2% during review period. Pain is complex, so there are many treatment options -- medications, therapies, and mind-body techniques. This report is mainly about the drugs for pain management. The leading manufacturers in the industry are GSK, Pfizer and Grune......

Global Fibromyalgia Drugs Market Research Report 2023, Forecast to 2028

Published: 28-Dec-2023        Price: US 2680 Onwards        Pages: 167

The FDA has approved three drugs to treat fibromyalgia: the antidepressants duloxetine (Cymbalta) and milnacipran (Savella), plus the anti-seizure medicine pregabalin (Lyrica). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging oppo......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs